{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:47:12Z","timestamp":1792720032473,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Scabies is an extremely fastidious infestation caused by the Sarcoptes scabiei mite. It causes a persistent itch that can disrupt a person\u2019s mental health, sleep, and overall quality of life. In endemic areas, treatment by targeting symptomatic individuals and their contacts is often unsuccessful due to an asymptomatic period and high rates of re-infection. To overcome this, Mass Drug Administration (MDA) is often used to treat the whole community, irrespective of whether individuals presently have scabies. This review summarises the evidence for the effectiveness of MDA in treating scabies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An exhaustive literature review was conducted on MEDLINE, EMBASE, Web of Science and Scopus. All peer-reviewed articles published in English January 1990 to March 2020 were eligible and only if the studies were primary and interventional. Furthermore, the intervention had to be a pharmacological MDA method involving human subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TWELVE articles that qualified for inclusion were identified. MDA for scabies significantly reduced its prevalence in communities at follow up. Some of the drivers of success were communities with low levels of migration, an uptake of MDA of\n                      <jats:underline>&gt;<\/jats:underline>\n                      \u200985%, the use of oral Ivermectin therapy, the treatment of children and pregnant women within the treated population, and repeated treatment for participants diagnosed with scabies at baseline.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The average absolute reduction in prevalence of scabies was 22.0% and the relative reduction average was 73.4%. These results suggest MDA is effective in treating scabies in the endemic community. Further evidence is needed surrounding MDA use in urban areas with increased levels of migration. Importantly, MDA should not substitute the tackling of socioeconomic factors which contribute to endemic disease such as good sanitation and hygiene.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40794-021-00143-5","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T20:04:50Z","timestamp":1625083490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mass drug administration for endemic scabies: a systematic review"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-4584","authenticated-orcid":false,"given":"Giulia","family":"Rinaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"2","key":"143_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1128\/CMR.00042-06","volume":"20","author":"SF Walton","year":"2007","unstructured":"Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev. 2007;20(2):268\u201379. https:\/\/doi.org\/10.1128\/CMR.00042-06.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"143_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13071-017-2234-1","volume":"10","author":"LG Arlian","year":"2017","unstructured":"Arlian LG, Morgan MS. A review of Sarcoptes scabiei: past, present and future. Parasit Vectors. 2017;10(1):297. https:\/\/doi.org\/10.1186\/s13071-017-2234-1.","journal-title":"Parasit Vectors"},{"key":"143_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF01193978","volume":"6","author":"LG Arlian","year":"1989","unstructured":"Arlian LG, Vyszenski-Moher DL, Pole MJ. Survival of adults and developmental stages ofSarcoptes scabiei var.canis when off the host. Exp Appl Acarol. 1989;6:181\u20137.","journal-title":"Exp Appl Acarol"},{"issue":"10","key":"143_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1468-3083.2010.03618.x","volume":"24","author":"A Jin-gang","year":"2010","unstructured":"Jin-gang A, Sheng-xiang X, Sheng-bin X, Jun-min W, Song-mei G, Ying-ying D, et al. Quality of life of patients with scabies. J Eur Acad Dermatol Venereol. 2010;24(10):1187\u201391. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03618.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"143_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.poamed.2015.04.002","volume":"22","author":"J Koryci\u0144ska","year":"2015","unstructured":"Koryci\u0144ska J, Dzika E, Lepczy\u0144ska M, Kubiak K. Scabies: clinical manifestations and diagnosis. Polish Ann Med. 2015;22(1):63\u20136. https:\/\/doi.org\/10.1016\/j.poamed.2015.04.002.","journal-title":"Polish Ann Med"},{"issue":"2","key":"143_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000495290","volume":"235","author":"DJ Chandler","year":"2019","unstructured":"Chandler DJ, Fuller LC. A review of scabies: an infestation more than skin deep. Dermatology. 2019;235(2):79\u201390. https:\/\/doi.org\/10.1159\/000495290.","journal-title":"Dermatology."},{"issue":"8","key":"143_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","volume":"15","author":"L Romani","year":"2015","unstructured":"Romani L, Steer AC, Whitfeld MJ, Kaldor JM. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis. 2015;15(8):960\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(15)00132-2.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"143_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-4632.2011.05017.x","volume":"51","author":"C Worth","year":"2012","unstructured":"Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Feldmeier H. Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol. 2012;51(3):275\u201382. https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05017.x.","journal-title":"Int J Dermatol"},{"issue":"4","key":"143_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1469-0691.2012.03798.x","volume":"18","author":"RJ Hay","year":"2012","unstructured":"Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world-its prevalence, complications, and management. Clin Microbiol Infect. 2012;18(4):313\u201323. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03798.x.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"143_CR10","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","volume":"17","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Colombara DV, Drucker AM, Norton SA, Hay R, Engelman D, et al. The global burden of scabies: a cross-sectional analysis from the global burden of disease study 2015. Lancet Infect Dis. 2017;17(12):1247\u201354. https:\/\/doi.org\/10.1016\/S1473-3099(17)30483-8.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"143_CR11","first-page":"513","volume":"65","author":"BKH Nair","year":"1977","unstructured":"Nair BKH, Joseph A, Kandamuthan M. Epidemic scabies. Indian J Med Res. 1977;65(4):513\u20138.","journal-title":"Indian J Med Res"},{"issue":"8","key":"143_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1365-4362.1998.00367.x","volume":"37","author":"D Landwehr","year":"1998","unstructured":"Landwehr D, Keita SM, Ponnighaus JM, Tounkara C. Epidemiologic aspects of scabies in Mali, Malawi, and Cambodia. Int J Dermatol. 1998;37(8):588\u201390. https:\/\/doi.org\/10.1046\/j.1365-4362.1998.00367.x.","journal-title":"Int J Dermatol"},{"issue":"11","key":"143_CR13","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1371\/journal.pntd.0000554","volume":"3","author":"RM Andrews","year":"2009","unstructured":"Andrews RM, Kearns T, Connors C, Parker C, Carville K, Currie BJ, et al. A regional initiative to reduce skin infections amongst Aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Neglected Trop Dis. 2009;3(11):e554. https:\/\/doi.org\/10.1371\/journal.pntd.0000554.","journal-title":"PLoS Neglected Trop Dis"},{"key":"143_CR14","volume-title":"Global Burden of Disease Data 2017","author":"GBD","year":"2017","unstructured":"GBD. Global Burden of Disease Data 2017. 2017."},{"issue":"5","key":"143_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1086\/504365","volume":"27","author":"G de Beer","year":"2006","unstructured":"de Beer G, Miller MA, Tremblay L, Monette J. An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control. Infect Control Hosp Epidemiol. 2006;27(5):517\u20138. https:\/\/doi.org\/10.1086\/504365.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9524","key":"143_CR16","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(06)68772-2","volume":"367","author":"J Heukelbach","year":"2006","unstructured":"Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367(9524):1767\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(06)68772-2.","journal-title":"Lancet"},{"issue":"1645","key":"143_CR17","doi-asserted-by":"publisher","first-page":"20130434","DOI":"10.1098\/rstb.2013.0434","volume":"369","author":"JP Webster","year":"2014","unstructured":"Webster JP, Molyneux DH, Hotez PJ, Fenwick A. The contribution of mass drug administration to global health: past, present and future. Philos Trans R Soc Lond Ser B Biol Sci. 2014;369(1645):20130434.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"2","key":"143_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/INF.0000000000002211","volume":"38","author":"LJ Thean","year":"2019","unstructured":"Thean LJ, Engelman D, Kaldor J, Steer AC. Scabies: new opportunities for management and population control. Pediatr Infect Dis J. 2019;38(2):211\u20133. https:\/\/doi.org\/10.1097\/INF.0000000000002211.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"143_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/inthealth\/ihy079","volume":"11","author":"N Kaehler","year":"2018","unstructured":"Kaehler N, Adhikari B, Cheah PY, Day NPJ, Paris DH, Tanner M, et al. The promise, problems and pitfalls of mass drug administration for malaria elimination: a qualitative study with scientists and policymakers. Int Health. 2018;11(3):166\u201376.","journal-title":"Int Health"},{"key":"143_CR20","volume-title":"Is mass drug administration the solution?","author":"Control of scabies in endemic areas","year":"2016","unstructured":"Control of scabies in endemic areas: Is mass drug administration the solution?, (2016)."},{"key":"143_CR21","volume-title":"WHO Informal Consultantion on a Framework for Scabies Conrol. Phillipines; 2020 19 February","author":"Organisation WH","year":"2019","unstructured":"Organisation WH. WHO Informal Consultantion on a Framework for Scabies Conrol. Phillipines; 2020 19 February 2019."},{"issue":"4","key":"143_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.5195\/JMLA.2018.513","volume":"106","author":"L Kellermeyer","year":"2018","unstructured":"Kellermeyer L, Harnke B, Knight S. Covidence and Rayyan. J Med Libr Assoc. 2018;106(4):580\u20133.","journal-title":"J Med Libr Assoc"},{"key":"143_CR23","volume-title":"World Bank country and lending groups","author":"Bank W","year":"2020","unstructured":"Bank W. World Bank country and lending groups. 2020."},{"key":"143_CR24","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ."},{"issue":"6","key":"143_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/cid\/ciy574","volume":"68","author":"M Marks","year":"2019","unstructured":"Marks M, Toloka H, Baker C, Kositz C, Asugeni J, Puiahi E, et al. Randomized trial of community treatment with azithromycin and Ivermectin mass drug Administration for Control of scabies and impetigo. Clin Infect Dis. 2019;68(6):927\u201333. https:\/\/doi.org\/10.1093\/cid\/ciy574.","journal-title":"Clin Infect Dis"},{"key":"143_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S1473-3099(18)30790-4","volume":"19","author":"L Romani","year":"2019","unstructured":"Romani L, Marks M, O. S, T. N, B. K, B. C, et al. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial. Lancet Infect Dis. 2019;19:510\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"143_CR27","first-page":"34","volume":"83","author":"G Lawrence","year":"2005","unstructured":"Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 2005;83(1):34\u201342.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"143_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/ijd.12353","volume":"53","author":"K Haar","year":"2014","unstructured":"Haar K, Romani L, Filimone R, Kishore K, Tuicakau M, Koroivueta J, et al. Scabies community prevalence and mass drug administration in two Fijian villages. Int J Dermatol. 2014;53(6):739\u201345. https:\/\/doi.org\/10.1111\/ijd.12353.","journal-title":"Int J Dermatol"},{"issue":"24","key":"143_CR29","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","volume":"373","author":"L Romani","year":"2015","unstructured":"Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass drug Administration for Scabies Control in a population with endemic disease. N Engl J Med. 2015;373(24):2305\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1500987.","journal-title":"N Engl J Med"},{"issue":"3","key":"143_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1365-2133.2000.03704.x","volume":"143","author":"B Leppard","year":"2000","unstructured":"Leppard B, Naburi AE. The use of ivermectin in controlling an outbreak of scabies in a prison. Br J Dermatol. 2000;143(3):520\u20133. https:\/\/doi.org\/10.1111\/j.1365-2133.2000.03704.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"143_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4269\/ajtmh.18-0018","volume":"99","author":"D Martin","year":"2018","unstructured":"Martin D, Wiegand R, Goodhew B, Lammie P, Mkocha H, Kasubi M, et al. Impact of ivermectin mass drug administration for lymphatic filariasis on scabies in eight villages in Kongwa District, Tanzania. Am J Trop Med Hyg. 2018;99(4):937\u20139. https:\/\/doi.org\/10.4269\/ajtmh.18-0018.","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"143_CR32","doi-asserted-by":"publisher","first-page":"e0004151","DOI":"10.1371\/journal.pntd.0004151","volume":"9","author":"TM Kearns","year":"2015","unstructured":"Kearns TM, Speare R, Cheng AC, McCarthy J, Carapetis JR, Holt DC, et al. Impact of an Ivermectin mass drug administration on scabies prevalence in a remote Australian Aboriginal community. PLoS Negl Trop Dis. 2015;9(10):e0004151. https:\/\/doi.org\/10.1371\/journal.pntd.0004151.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"143_CR33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/00006454-199705000-00008","volume":"16","author":"JR Carapetis","year":"1997","unstructured":"Carapetis JR, Connors C, Yarmirr D, Krause V, Currie BJ. Success of a scabies control program in an Australian Aboriginal community. Pediatr Infect Dis J. 1997;16(5):494\u20139. https:\/\/doi.org\/10.1097\/00006454-199705000-00008.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"143_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0001-706X(99)00087-X","volume":"75","author":"MJ Bockarie","year":"2000","unstructured":"Bockarie MJ, Alexander ND, Kazura JW, Bockarie F, Griffin L, Alpers MP. Treatment with ivermectin reduces the high prevalence of scabies in a village in Papua New Guinea. Acta Trop. 2000;75(1):127\u201330. https:\/\/doi.org\/10.1016\/S0001-706X(99)00087-X.","journal-title":"Acta Trop"},{"key":"143_CR35","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/0140-6736(91)92669-S","volume":"337","author":"D Taplin","year":"1991","unstructured":"Taplin D, Porcelain SL, Meinking TL, Athey RL, Chen JA, Castillero PM, et al. Community control of scabies: a model based on use of permethrin cream. Lancet (London, England). 1991;337:1016\u20138.","journal-title":"Lancet (London, England)"},{"key":"143_CR36","doi-asserted-by":"publisher","unstructured":"Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;2013(12:CD008846. https:\/\/doi.org\/10.1002\/14651858.CD008846.pub2.","DOI":"10.1002\/14651858.CD008846.pub2"},{"issue":"10066","key":"143_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0140-6736(16)32123-7","volume":"389","author":"NE Clarke","year":"2017","unstructured":"Clarke NE, Clements ACA, Doi SA, Wang D, Campbell SJ, Gray D, et al. Differential effect of mass deworming and targeted deworming for soil-transmitted helminth control in children: a systematic review and meta-analysis. Lancet. 2017;389(10066):287\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(16)32123-7.","journal-title":"Lancet"},{"issue":"1","key":"143_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13071-018-2821-9","volume":"11","author":"RS Nicholls","year":"2018","unstructured":"Nicholls RS, Duque S, Olaya LA, L\u00f3pez MC, S\u00e1nchez SB, Morales AL, et al. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world. Parasit Vectors. 2018;11(1):237. https:\/\/doi.org\/10.1186\/s13071-018-2821-9.","journal-title":"Parasit Vectors"},{"key":"143_CR39","unstructured":"WHO. Global programme to eliminate lymphatic filariasis: progress report, 2014: World Health Organisation; 2015. Contract No.: 38"},{"issue":"5","key":"143_CR40","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1371\/journal.pntd.0000444","volume":"3","author":"S La Vincente","year":"2009","unstructured":"La Vincente S, Kearns T, Connors C, Cameron S, Carapetis J, Andrews R. Community management of endemic scabies in remote Aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition. PLoS Negl Trop Dis. 2009;3(5):e444. https:\/\/doi.org\/10.1371\/journal.pntd.0000444.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"143_CR41","doi-asserted-by":"publisher","first-page":"e0006043","DOI":"10.1371\/journal.pntd.0006043","volume":"11","author":"M Burnim","year":"2017","unstructured":"Burnim M, Ivy JA, King CH. Systematic review of community-based, school-based, and combined delivery modes for reaching school-aged children in mass drug administration programs for schistosomiasis. PLoS Negl Trop Dis. 2017;11(10):e0006043. https:\/\/doi.org\/10.1371\/journal.pntd.0006043.","journal-title":"PLoS Negl Trop Dis"},{"key":"143_CR42","doi-asserted-by":"publisher","unstructured":"Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018;4(4):CD012994. https:\/\/doi.org\/10.1002\/14651858.CD012994.","DOI":"10.1002\/14651858.CD012994"},{"issue":"4","key":"143_CR43","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bjd.18788","volume":"182","author":"R Morris-Jones","year":"2020","unstructured":"Morris-Jones R. Oral ivermectin for infants and children under 15 kg appears to be a safe and effective treatment for scabies. Br J Dermatol. 2020;182(4):835\u20136. https:\/\/doi.org\/10.1111\/bjd.18788.","journal-title":"Br J Dermatol"},{"key":"143_CR44","doi-asserted-by":"publisher","unstructured":"Coscione S, Esau T, Kekeubata E, Diau J, Asugeni R, MacLaren D, Steer AC, Kositz C, Marks M. Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands. PLoS Negl Trop Dis. 2018;12(9):e0006825. https:\/\/doi.org\/10.1371\/journal.pntd.0006825.","DOI":"10.1371\/journal.pntd.0006825"},{"issue":"3","key":"143_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/trstmh\/trx025","volume":"111","author":"C Kositz","year":"2017","unstructured":"Kositz C, Talina J, Diau J, Asugeni R, Whitehorn C, Mabey D, et al. Incidental mosquitocidal effect of an ivermectin mass drug administration on Anopheles farauti conducted for scabies control in the Solomon Islands. Trans R Soc Trop Med Hyg. 2017;111(3):97\u2013101. https:\/\/doi.org\/10.1093\/trstmh\/trx025.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"143_CR46","doi-asserted-by":"publisher","first-page":"e0005607","DOI":"10.1371\/journal.pntd.0005607","volume":"11","author":"TM Kearns","year":"2017","unstructured":"Kearns TM, Currie BJ, Cheng AC, McCarthy J, Carapetis JR, Holt DC, et al. Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community. PLoS Negl Trop Dis. 2017;11(5):e0005607. https:\/\/doi.org\/10.1371\/journal.pntd.0005607.","journal-title":"PLoS Negl Trop Dis"},{"key":"143_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(09)61422-7","volume":"375","author":"L Conteh","year":"2010","unstructured":"Conteh L, Engels T, Molyneux DH. Socioeconomic aspects of neglected tropical diseases. Lancet (London, England). 2010;375:239\u201347.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"143_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40249-019-0558-0","volume":"8","author":"FO Richards","year":"2019","unstructured":"Richards FO, Nwoke BEB, Zarroug I, Tukahebwa E, Negussu N, Higazi TB, et al. The positive influence the onchocerciasis elimination program for the Americas has had on Africa programs. Infect Dis Poverty. 2019;8(1):52. https:\/\/doi.org\/10.1186\/s40249-019-0558-0.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"143_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40249-016-0160-7","volume":"5","author":"AH Tekle","year":"2016","unstructured":"Tekle AH, Zour\u00e9 HGM, Noma M, Boussinesq M, Coffeng LE, Stolk WA, et al. Progress towards onchocerciasis elimination in the participating countries of the African Programme for onchocerciasis control: epidemiological evaluation results. Infect Dis Poverty. 2016;5(1):66. https:\/\/doi.org\/10.1186\/s40249-016-0160-7.","journal-title":"Infect Dis Poverty"},{"issue":"8","key":"143_CR50","doi-asserted-by":"publisher","first-page":"e0006551","DOI":"10.1371\/journal.pntd.0006551","volume":"12","author":"RN Bronzan","year":"2018","unstructured":"Bronzan RN, Dorkenoo AM, Agbo YM, Halatoko W, Layibo Y, Adjeloh P, et al. Impact of community-based integrated mass drug administration on schistosomiasis and soil-transmitted helminth prevalence in Togo. PLoS Negl Trop Dis. 2018;12(8):e0006551. https:\/\/doi.org\/10.1371\/journal.pntd.0006551.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"143_CR51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.trstmh.2007.03.006","volume":"101","author":"A Olsen","year":"2007","unstructured":"Olsen A. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans R Soc Trop Med Hyg. 2007;101(8):747\u201358. https:\/\/doi.org\/10.1016\/j.trstmh.2007.03.006.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"16","key":"143_CR52","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1001\/jama.298.16.1911","volume":"298","author":"M Reddy","year":"2007","unstructured":"Reddy M, Gill SS, Kalkar SR, Wu W, Anderson PJ, Rochon PA. Oral drug therapy for multiple neglected tropical diseases: a systematic review. JAMA. 2007;298(16):1911\u201324. https:\/\/doi.org\/10.1001\/jama.298.16.1911.","journal-title":"JAMA."},{"key":"143_CR53","doi-asserted-by":"publisher","first-page":"105182","DOI":"10.1016\/j.actatropica.2019.105182","volume":"202","author":"PJ Hotez","year":"2020","unstructured":"Hotez PJ. The rise or fall of neglected tropical diseases in East Asia Pacific. Acta Trop. 2020;202:105182. https:\/\/doi.org\/10.1016\/j.actatropica.2019.105182.","journal-title":"Acta Trop"},{"key":"143_CR54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/1756-3305-5-299","volume":"5","author":"KA Mohammed","year":"2012","unstructured":"Mohammed KA, Deb RM, Stanton MC, Molyneux DH. Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact. Parasit Vectors. 2012;5:299.","journal-title":"Parasit Vectors"},{"key":"143_CR55","doi-asserted-by":"publisher","first-page":"e171-e","DOI":"10.1371\/journal.pntd.0000171","volume":"2","author":"KA Mohammed","year":"2008","unstructured":"Mohammed KA, Haji HJ, Gabrielli A-F, Mubila L, Biswas G, Chitsulo L, et al. Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study. PLoS neglected Trop Dis. 2008;2:e171-e.","journal-title":"PLoS neglected Trop Dis"},{"issue":"4","key":"143_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.trstmh.2010.11.012","volume":"105","author":"H Namwanje","year":"2011","unstructured":"Namwanje H, Kabatereine N, Olsen A. A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda. Trans R Soc Trop Med Hyg. 2011;105(4):181\u20138. https:\/\/doi.org\/10.1016\/j.trstmh.2010.11.012.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"143_CR57","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1179\/2047773211Y.0000000010","volume":"105","author":"D Evans","year":"2011","unstructured":"Evans D, McFarland D, Adamani W, Eigege A, Miri E, Schulz J, et al. Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria. Ann Trop Med Parasitol. 2011;105(8):537\u201347. https:\/\/doi.org\/10.1179\/2047773211Y.0000000010.","journal-title":"Ann Trop Med Parasitol"},{"key":"143_CR58","doi-asserted-by":"publisher","first-page":"e0005030-e","DOI":"10.1371\/journal.pntd.0005030","volume":"10","author":"C Bernigaud","year":"2016","unstructured":"Bernigaud C, Fang F, Fischer K, Lespine A, Aho LS, Dreau D, et al. Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model. PLoS Neglected Trop Dis. 2016;10:e0005030-e.","journal-title":"PLoS Neglected Trop Dis"},{"key":"143_CR59","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.12688\/gatesopenres.13064.1","volume":"3","author":"M Marks","year":"2019","unstructured":"Marks M, McVernon J, Engelman D, Kaldor J, Steer A. Insights from mathematical modelling on the proposed WHO 2030 goals for scabies. Gates Open Res. 2019;3:1542. https:\/\/doi.org\/10.12688\/gatesopenres.13064.1.","journal-title":"Gates Open Res"},{"issue":"2","key":"143_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1056\/NEJMc1808439","volume":"381","author":"L Romani","year":"2019","unstructured":"Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass drug Administration for Scabies \u2014 2 years of follow-up. N Engl J Med. 2019;381(2):186\u20137. https:\/\/doi.org\/10.1056\/NEJMc1808439.","journal-title":"N Engl J Med"},{"issue":"6","key":"143_CR61","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/cid\/ciy574","volume":"68","author":"M Marks","year":"2019","unstructured":"Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, et al. Prevalence of scabies and impetigo three years after mass drug administration with ivermectin and azithromycin. Clin Infect Dis. 2019;68(6):927\u201333. https:\/\/doi.org\/10.1093\/cid\/ciy574.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"143_CR62","doi-asserted-by":"publisher","first-page":"e0004246","DOI":"10.1371\/journal.pntd.0004246","volume":"9","author":"M Marks","year":"2015","unstructured":"Marks M, Taotao-Wini B, Satorara L, Engelman D, Nasi T, Mabey DC, et al. Long term control of scabies fifteen years after an intensive treatment Programme. PLoS Negl Trop Dis. 2015;9(12):e0004246. https:\/\/doi.org\/10.1371\/journal.pntd.0004246.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"143_CR63","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1046\/j.1440-0960.2002.00626.x","volume":"43","author":"L-C Wong","year":"2002","unstructured":"Wong L-C, Amega B, Barker R, Connors C, Dulla ME, Ninnal A, et al. Factors supporting sustainability of a community-based scabies control program. Australas J Dermatol. 2002;43(4):274\u20137. https:\/\/doi.org\/10.1046\/j.1440-0960.2002.00626.x.","journal-title":"Australas J Dermatol"},{"issue":"9","key":"143_CR64","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.4103\/jfmpc.jfmpc_503_19","volume":"8","author":"S Banerjee","year":"2019","unstructured":"Banerjee S, Bandyopadhyay K, Khan MF, Akkilagunta S, Selvaraj K, Tripathy JP, et al. Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: a mixed method study. J Family Med Prim Care. 2019;8(9):3009\u201314. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_503_19.","journal-title":"J Family Med Prim Care"}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-021-00143-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-021-00143-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-021-00143-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T20:21:18Z","timestamp":1625084478000},"score":1,"resource":{"primary":{"URL":"https:\/\/tdtmvjournal.biomedcentral.com\/articles\/10.1186\/s40794-021-00143-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1186\/s40794-021-00143-5","relation":{},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}